Sign up
Log in
12 Health Care Stocks Moving In Friday's Pre-Market Session
Share
Listen to the news

Gainers

  • BioLine Rx (NASDAQ:BLRX) stock increased by 67.5% to $6.35 during Friday's pre-market session. The market value of their outstanding shares is at $23.6 million. As per the press release, Q1 earnings came out 3 days ago.
  • Basel Medical Group (NASDAQ:BMGL) stock rose 20.19% to $1.25. The market value of their outstanding shares is at $23.4 million.
  • Psyence Biomedical (NASDAQ:PBM) stock increased by 10.92% to $5.79. The market value of their outstanding shares is at $3.3 million.
  • VSee Health (NASDAQ:VSEE) stock increased by 10.28% to $1.3. The market value of their outstanding shares is at $20.4 million.
  • Reviva Pharmaceuticals (NASDAQ:RVPH) stock moved upwards by 9.98% to $0.98. The market value of their outstanding shares is at $45.8 million.
  • I-MAB (NASDAQ:IMAB) stock moved upwards by 9.52% to $1.38. The company's market cap stands at $111.6 million.

Losers

  • CollPlant Biotechnologies (NASDAQ:CLGN) stock declined by 23.0% to $3.5 during Friday's pre-market session. The market value of their outstanding shares is at $40.0 million. As per the press release, Q1 earnings came out 2 days ago.
  • CERo Therapeutics Hldgs (NASDAQ:CERO) shares fell 20.28% to $0.41. The market value of their outstanding shares is at $3.1 million.
  • Genprex (NASDAQ:GNPX) shares fell 15.95% to $0.28. The market value of their outstanding shares is at $7.7 million.
  • NeuroPace (NASDAQ:NPCE) shares fell 14.8% to $11.17. The company's market cap stands at $366.3 million.
  • Entero Therapeutics (NASDAQ:ENTO) shares declined by 13.23% to $0.36. The company's market cap stands at $1.7 million.
  • Harvard Bioscience (NASDAQ:HBIO) shares decreased by 13.0% to $0.58. The company's market cap stands at $25.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.